3 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing TreatmentDigestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitisActive, not recruitingNot stated2026-10-01NCT06447168
Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid TumorsAdvanced Solid TumorsRecruitingPhase 12026-08-13NCT06384352
A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NETdigestive system neuroendocrine neoplasmActive, not recruitingPhase 32026-07-28NCT05050942